ASH Increases Investment in Hematology Research and Training
The American Society of Hematology (ASH) posted on X:
“1/8
ASH increased its investment in hematology research & training, which means more opportunities right now to receive funding!
See the thread for open opportunities by career stage.
Help us share!
2/8
Projects below are based in North America. Find global awards here.
You are encouraged to apply for all awards for which you are eligible; however, please note that only one award may be accepted at a time
3/8
Medstudent Funding for a part-time or 1-year immersive project
ASH HIP Medical Student Award | Part-time or immersive project
ASH HONORS | Part time
ASH Physician-Scientist Award | Immersive
4/8
PhD students: Receive $40,000 annually for 2 years of tuition/salary/honorarium, research, & training w/ these opportunities.
ASH Graduate Hematology Award | here
ASH HIP Graduate Student Award | here
5/8
Residents: Receive career mentorship and $5,000 for your part-time research project to take place over 3-12 months with these awards:
ASH HIP Resident Award | here
ASH HONORS | here
6/8
Fellows & junior faculty — Research awards
ASH HIP Fellow Award | $100,000 over 2-3 years for protected research time and training
RTAF | $70,000 for one year protected research time
7/8
Fellows and junior faculty — Training opportunities
Clinical Research Training Institute | In-person and distance learning & mentorship
8/8
The ASH Treating Fairly is a new award for ASH members who are PIs for research on hematologic diseases & disorders disproportionately affecting vulnerable communities.
Protect your research amid federal cuts here.
Stay updated with Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!